Borosil Scientific Limited (BOM:544184)
India · Delayed Price · Currency is INR 109.95
-1.20 (-1.08%)
At close: Nov 9, 2026
Borosil Scientific Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 4,862 | 4,673 | 4,385 | 3,960 | 984.08 | 1,064 |
Revenue Growth | 12.07% | 6.58% | 10.73% | 302.39% | -7.54% | 62.73% |
Gross Profit Gross Profit Growth | 3,166 | 2,973 | 2,746 | 2,491 | 539.37 | 591.27 |
Operating Income Operating Income Growth | 495.65 | 437.26 | 343.09 | 304.15 | 24.79 | 108.7 |
Net Income Net Income Growth | 455.69 | 346.14 | 268.04 | 235.59 | 20.64 | 85.68 |
Earnings Per Share EPS Growth | 5.18 | 3.89 | 3.02 | 2.65 | 12.64 | 58.94 |
EPS Growth | 298.06% | 28.95% | 13.84% | -79.03% | -78.55% | 570.67% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Scientific – Laboratory Glass & Equipment and Process System Scientific – Laboratory Glass & Equipment and Process System Growth | 3,416 | 3,309 | 3,099 | 2,656 |
Others Others Growth | - | 56.19 | 48.55 | 34.95 |
Glassware Glassware Growth | - | 1,308 | 1,237 | 1,268 |
Total Total Growth | 4,862 | 4,673 | 4,385 | 3,960 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 1,347 | 1,356 | 1,187 | 121.29 | 326.12 | 92.61 |
Total Debt Total Debt Growth | 57.98 | 86.3 | 144.38 | 177.71 | 457.75 | - |
Net Cash (Debt) Net Cash Growth | 1,289 | 1,270 | 1,043 | -56.42 | -131.64 | 92.61 |
Net Cash Growth | 19.78% | 21.75% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 14.65 | 14.27 | 11.74 | -0.64 | -80.61 | 63.71 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 528.24 | 432.7 | 1,200 | 300.02 | -14.26 | 92.19 |
Capital Expenditures CapEx Growth | -386.63 | -284.53 | -141.64 | -128.74 | -209.63 | -131.62 |
Free Cash Flow Free Cash Flow Growth | 141.61 | 148.18 | 1,059 | 171.27 | -223.9 | -39.44 |
Free Cash Flow Growth | -86.44% | -86.00% | 518.11% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 65.11% | 63.61% | 62.63% | 62.91% | 54.81% | 55.55% |
Operating Margin | 10.20% | 9.36% | 7.82% | 7.68% | 2.52% | 10.21% |
Pretax Margin | 11.40% | 9.17% | 9.21% | 7.97% | 3.02% | 10.64% |
Profit Margin | 9.37% | 7.41% | 6.11% | 5.95% | 2.10% | 8.05% |
FCF Margin | 2.91% | 3.17% | 24.14% | 4.32% | -22.75% | -3.71% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 21.23 | 26.48 | 40.53 | - | - | - |
P/FCF Ratio | 69.06 | 61.86 | 10.26 | - | - | - |
PS Ratio | 2.01 | 1.96 | 2.48 | - | - | - |